Norwegian Centre for Integrated Care and Telemedicine, University Hospital of North Norway, PO Box 6060, N-9038 Tromsø, Norway.
BMC Health Serv Res. 2011 Aug 8;11:185. doi: 10.1186/1472-6963-11-185.
A major benefit offered by telemedicine is the avoidance of travel, by patients, their carers and health care professionals. Unfortunately, there is very little published information about the extent of avoided travel. We propose to undertake a systematic review of literature which reports credible data on the reductions in travel associated with the use of telemedicine.
The conventional approach to quantitative synthesis of the results from multiple studies is to conduct a meta analysis. However, too much heterogeneity exists between available studies to allow a meaningful meta analysis of the avoided travel when telemedicine is used across all possible settings. We propose instead to consider all credible evidence on avoided travel through telemedicine by fitting a linear model which takes into account the relevant factors in the circumstances of the studies performed. We propose the use of stepwise multiple regression to identify which factors are significant.
Our proposed approach is illustrated by the example of teledermatology. In a preliminary review of the literature we found 20 studies in which the percentage of avoided travel through telemedicine could be inferred (a total of 5199 patients). The mean percentage avoided travel reported in the 12 store-and-forward studies was 43%. In the 7 real-time studies and in a single study with a hybrid technique, 70% of the patients avoided travel. A simplified model based on the modality of telemedicine employed (i.e. real-time or store and forward) explained 29% of the variance. The use of store and forward teledermatology alone was associated with 43% of avoided travel. The increase in the proportion of patients who avoided travel (25%) when real-time telemedicine was employed was significant (P = 0.014). Service planners can use this information to weigh up the costs and benefits of the two approaches.
远程医疗的一个主要优势是避免患者、其护理人员和医疗保健专业人员的出行。不幸的是,关于使用远程医疗避免出行的程度,发表的信息很少。我们建议对报告使用远程医疗可减少出行相关数据的文献进行系统综述。
对多项研究结果进行定量综合的传统方法是进行荟萃分析。然而,由于可用研究之间存在太大的异质性,无法对远程医疗在所有可能的环境中使用时的避免出行进行有意义的荟萃分析。因此,我们建议通过拟合线性模型来考虑通过远程医疗避免出行的所有可信证据,该模型考虑了所进行研究情况中的相关因素。我们建议使用逐步多元回归来确定哪些因素是重要的。
我们提出的方法通过远程皮肤病学的例子来说明。在对文献的初步回顾中,我们发现了 20 项可以推断出通过远程医疗避免出行的百分比的研究(共 5199 名患者)。在 12 项存储和转发研究中报告的平均避免出行百分比为 43%。在 7 项实时研究和一项具有混合技术的研究中,有 70%的患者避免了出行。基于所使用的远程医疗模式(即实时或存储和转发)的简化模型解释了 29%的方差。单独使用存储和转发远程皮肤病学与 43%的避免出行有关。当使用实时远程医疗时,避免出行的患者比例(25%)增加具有显著意义(P=0.014)。服务规划者可以使用这些信息权衡这两种方法的成本和效益。